MARKET

IVIXF

IVIXF

Invion Ltd
OTCPK
0.0018
NaN%
Opening 09:30 06/10 EDT
OPEN
--
PREV CLOSE
0.0018
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0018
52 WEEK LOW
0.0018
MARKET CAP
174.54K
P/E (TTM)
-0.0204
1D
5D
1M
3M
1Y
5Y
1D
Invion secures strong shareholder backing for capital measures at EGM
TipRanks · 05/29 07:27
Invion corrects director shareholding disclosure in ASX filing
TipRanks · 05/11 06:49
Invion Options Lapse, Trimming Potential Future Dilution
TipRanks · 05/01 04:57
Invion bolsters funding as Photosoft cancer programs show promising progress
TipRanks · 04/30 02:04
Invion convenes virtual general meeting to vote on fair and reasonable transaction
TipRanks · 04/28 01:07
Invion to Showcase Photodynamic Cancer Therapy at Major Asian Biotech Conferences
TipRanks · 04/21 23:07
Invion Expands INV043 Skin Cancer Trial to Basal Cell Carcinoma After Strong Safety Data
TipRanks · 04/21 00:05
Invion Updates Director Interest Disclosure to Strengthen Governance
TipRanks · 04/20 02:37
More
About IVIXF
Invion Limited is an Australia-based life science company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. It holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.

Webull offers Invion Ltd stock information, including OTCPK: IVIXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IVIXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IVIXF stock methods without spending real money on the virtual paper trading platform.